Indies Pharma Jamaica Limited

JMSE:INDIES Stock Report

Market Cap: JA$4.5b

Indies Pharma Jamaica Past Earnings Performance

Past criteria checks 2/6

Indies Pharma Jamaica has been growing earnings at an average annual rate of 8.8%, while the Healthcare industry saw earnings growing at 13.8% annually. Revenues have been growing at an average rate of 9.9% per year. Indies Pharma Jamaica's return on equity is 17.1%, and it has net margins of 19.1%.

Key information

8.8%

Earnings growth rate

8.2%

EPS growth rate

Healthcare Industry Growth-2.9%
Revenue growth rate9.9%
Return on equity17.1%
Net Margin19.1%
Last Earnings Update31 Oct 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Indies Pharma Jamaica makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

JMSE:INDIES Revenue, expenses and earnings (JMD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Oct 241,1592215040
31 Jul 241,1362163440
30 Apr 241,1392563440
31 Jan 241,0692173420
31 Oct 231,0552133120
31 Jul 239972063390
30 Apr 239621943000
31 Jan 239812302810
31 Oct 229372212740
31 Jul 229412522760
30 Apr 228842222700
31 Jan 228361712620
31 Oct 218471682440
31 Jul 218331522510
30 Apr 217911592400
31 Jan 217962152300
31 Oct 207662072460
31 Jul 207191772650
30 Apr 207691612950
31 Jan 207551243140
31 Oct 197291312950
31 Jul 197631533040
30 Apr 196961502690
31 Jan 196531432240
31 Oct 186361202100
31 Jul 186221232210
30 Apr 186471351910
31 Jan 186351351900
31 Oct 176201371860
31 Oct 16587792480

Quality Earnings: INDIES has high quality earnings.

Growing Profit Margin: INDIES's current net profit margins (19.1%) are lower than last year (20.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: INDIES's earnings have grown by 8.8% per year over the past 5 years.

Accelerating Growth: INDIES's earnings growth over the past year (3.8%) is below its 5-year average (8.8% per year).

Earnings vs Industry: INDIES earnings growth over the past year (3.8%) did not outperform the Healthcare industry 15.6%.

Return on Equity

High ROE: INDIES's Return on Equity (17.1%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/16 14:07
End of Day Share Price 2025/02/14 00:00
Earnings2024/10/31
Annual Earnings2024/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Indies Pharma Jamaica Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.